Basophil activation test to BNT162b2 lacks specificity for predicting allergic reactions to the mRNA vaccine

Basophil activation test to BNT162b2 lacks specificity for predicting allergic reactions to the mRNA vaccine

Background: Allergic reactions to the coronavirus 2019 disease (COVID-19) mRNA vaccine (BNT162b2) were originally reported at higher rates than expected, contributing to vaccine hesitancy and, in some cases, unnecessary vaccine avoidance. Identification of a test that accurately predicts allergic re...

Full description

Saved in:
Bibliographic Details
Main Authors: Sydney Ann Kee, PhD, Ana Olivera, PhD, Lindsay Chatman, MSc, Muhammad B. Khalid, MD, Min Jenny Li, PhD, Eric Chu, MA, Ellen Zektser, BSN, MPH, Karen Laky, PhD, Pamela A. Frischmeyer-Guerrerio, MD, PhD
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Journal of Allergy and Clinical Immunology: Global
Subjects:
Basophil activation test
BAT
COVID-19 mRNA vaccine
vaccine reactions
vaccine allergy
polyethylene glycol
Online Access:http://www.sciencedirect.com/science/article/pii/S2772829325000967
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2772829325000967

Similar Items